StockTipsArenaBeta

BUY Divi's Laboratories Limited — Goldman Sachs

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byGoldman SachsHorizon: NA (inferred 1 year)9 Nov 2026via ET Now (Live)

Entry₹11,097Inferred
Target₹11,700
Total upside +5.43% (call closed)
Stop lossNot given
Exit₹11,7009 Nov 2026, 7:46 am
Target hit+5.43%0.00%upside left
Follow Goldman Sachs for new calls(100% target hit, 47 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 7 active Long-term calls on DIVISLABSee 273 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 9 Nov 2026
7 supporting4 neutral2 opposing
Supports the BUY call (7)

Divi's Laboratories share price: JPMorgan upgrades, Goldman raises earnings estimates after strong Q2

NewsCnbc-Tv18·9 Nov · today

(opens in new tab)

Muhurat Trading 2026: Finolex Cables Jumps 17% As Samvat 2083 Begins. These Stocks Are Also Rallying

NewsNdtv-Profit·8 Nov · today

(opens in new tab)

2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·9 Nov · today

Divi's Laboratories Q2 Results: Net Profit Jumps 64% To Rs 1,127 Crore, Revenue Rises 35%; Margins Expand

NewsNdtv-Profit·7 Nov · yesterday

(opens in new tab)

Divi's Laboratories shares in focus as weight loss drug receives EU panel backing

NewsCnbc-Tv18·19 Oct · 3w ago

(opens in new tab)
Neutral / worth noting (4)

Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·7 Nov · yesterday

(opens in new tab)
Weighs against the BUY call (2)

3 other SEBI-registered advisors have active long-term SELL calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·26 Oct · 2w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Goldman Sachs

Every call and its outcome